AHF Endorses Senate Committee Proposal to Detach R&D from Drug Pricing

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) has released the following statement regarding the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee’s latest efforts to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA):

“AIDS Healthcare Foundation welcomes the U.S. Senate HELP Committee’s bipartisan approach to reauthorize pandemic preparedness legislation. The Pandemic and All-Hazards Preparedness Act will protect against disruptions to the nation’s supply of critical pharmaceuticals,” said Michael Weinstein, AHF president and cofounder. “AHF applauds U.S. Senators Bernie Sanders (I-Vt.) and Bill Cassidy (R-La.) for the prize research study provision within PAHPA that will evaluate new models for biomedical research that do not rely on the for-profit motives of drug companies. Alternatives to the traditional model that link R&D costs to drug prices will benefit all Americans.”

AIDS Healthcare Foundation (AHF), the largest global HIV and AIDS organization, provides medical care and/or services to more that 1.7 million individuals in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, please visit our website, find us on Facebook, follow us on IG and Twitter, or subscribe to our “AHFter Hours” podcast.